Search NLS News

Sigrid Therapeutics has announced that the European Patent Office has granted the company patent titled “A porous silica material for use as a pharmaceutical or dietary active ingredient”. The patent supports use of Sigrid’s mesoporous silica particles (MSP)-based device which consists of precisely engineered micron-sized silica particles with tailored porosity designed to act locally in […]

In response to Russia’s military attack on Ukraine, NordForsk has decided that co-operation projects with Russia will be suspended. “Following the attack on Ukraine, both the Nordic Council of Ministers and the authorities in the Nordic countries have decided to halt cooperation with Russia in a number of areas. We believe it is appropriate to […]

The Russian invasion of Ukraine has, and will, affect the lives of millions of people and many life science companies and organizations are offering humanitarian support, including donations of medical supplies and financial support. The Novo Nordisk Foundation has for example donated approximately 7.4 million EUR, including approximately 700 000 EUR to the UNHC, to […]

On International Women’s Day we like to highlight some of the many inspiring women in life science that we have had the opportunity to meet and interview. Within life science business Nordic Life Science has interviewed both young aspiring female entrepreneurs as well as well-established business leaders.     Malin Parkler     “Define how […]

On International Women’s Day we like to highlight some of the many inspiring women in life science that we have had the opportunity to meet and interview. Within life science research Nordic Life Science has interviewed both young female scientists at the beginning of their careers as well as well-established female scientists – including several […]

APLEX Bio, developer of a next-generation massively multiplexed (hyperplexed) molecular detection technology based on research in collaboration with Professor Mats Nilsson’s laboratory at SciLifeLab, launches company. The company is based in Stockholm at the Karolinska Institute (KI) campus and is a part of KI Innovations. “We have developed a unique technology that combines cutting edge […]

Vakona has signed an agreement with French company GTP Tech to initiate the first manufacturing steps of its acne medicine. GTP Tech, a GTP Bioways company, will develop the industrial process to move on from the preclinical phase towards the manufacturing of antibiotic-free treatment for clinics. “This agreement is a big step forward for us. […]

Detailed results from the MELODY Phase III trial showed a single dose of AstraZeneca and Sanofi’s nirsevimab met the primary efficacy endpoint reducing the incidence of medically attended lower respiratory tract infections (LRTI) caused by respiratory syncytial virus (RSV) by 74.5%, compared to placebo. The trial involved healthy term and late preterm (gestational age ≥35 […]

Johan von Schreeb, Professor of global disaster medicine and Head of the Centre for Research on Health Care in Disasters at Karolinska Institutet, has been named Director of Karolinska Institutet’s (KI) newly established Health Emergency and Pandemic Science Center. The aim is to create a center based on KI’s knowledge and capability, that finds connections […]

Bio-Me has announced that Warren Flood has become CEO following a successful period as COO. Previous CEO, Morten Isaksen, moves up to the Board and will also continue as Chief Innovation Officer with a focus on longer term and higher value clinical applications for the company’s Precision Microbiome Profiling (PMP) technology, states the company. “We […]